Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial
Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Osteoporosis International
Authors: C. C. Mok, K. H. Tong, C. H. To, Y. P. Siu, K. M. Ma
Institution: Tuen Mun Hospital
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Sanofi
OpenAlex ID: W2005294035